News

Agravitae Is The World’s Direct Sales/Network Marketing Company Representing A Soil-to-Shelf, Graviola Superfood Premium Product Line

TUSTIN, CA / ACCESSWIRE / July 12, 2022 / For generations, the graviola fruit (soursop) has been revered as a…

2 years ago

Relatient Partners with TriZetto Provider Solutions to Offer Suite of Patient Scheduling and Engagement Solutions to Network of Providers

Dash® by Relatient enables centralized self-scheduling, messaging, chat, and digital intake NASHVILLE, Tenn.--(BUSINESS WIRE)--Relatient, Inc., the leading SaaS-based patient scheduling…

2 years ago

Cosmos Holdings Subsidiary Granted Full Membership in PAGB, A UK-based Consumer Healthcare Association

Products will be listed on PAGB's OTC Directory online, a go-to resource for healthcare professionalsCHICAGO, IL / ACCESSWIRE / July…

2 years ago

Altamira Therapeutic’s RNA Delivery Platform Shown to be an Effective Treatment for Abdominal Aortic Aneurysm as Published in Peer-Reviewed Journal

Study results appeared in "Biomaterials Advances", a highly respected peer-reviewed journal, showcasing growing medical recognition of Company's patented RNA delivery…

2 years ago

Integra Pharma Solutions, LLC (d/b/a TRxADE Prime(TM) (a TRxADE HEALTH Company) Secures Preferred Distribution Agreement with GALT Pharmaceuticals, LLC

TAMPA, FL / ACCESSWIRE / July 12, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS) ("TRxADE" or the "Company") an integrated drug…

2 years ago

Teladoc Health to Announce Second Quarter 2022 Financial Results

PURCHASE, NY, July 12, 2022 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care,…

2 years ago

Forza Innovations Inc. Announces Sustainable Origins Operations Update

SAN DIEGO, CA, July 12, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Forza Innovations Inc.  (OTC Pink: FORZ) (the “Company”…

2 years ago

CohBar Appoints Effie Tozzo, Ph.D. to Its Board of Directors

MENLO PARK, Calif., July 12, 2022 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company leveraging the…

2 years ago

AXIM Biotechnologies Publishes Study Highlighting Neutralizing Antibody Levels of Poor Vaccine Responders with a Third COVID-19 Vaccine Dose

SAN DIEGO, July 12, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an…

2 years ago

Y-mAbs’ Announces Clearance of IND for GD2-SADA

NEW YORK, July 12, 2022 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical…

2 years ago